Research Project
Project Title: |
Phase 2a Study of VX-147 in Adults With APOL1-mediated Focal Segmental Glomerulosclerosis |
Project Type: |
Clinical Trial, Enrolment ongoing |
Disease group(s): |
Hereditary glomerulopathies |
Project Summary: |
This study will evaluate the efficacy, safety and pharmacokinetics (PK) of VX-147 in subjects with apolipoprotein L1 (APOL1)-mediated focal segmental glomerulosclerosis (FSGS). |
Lead principal investigator(s): |
Bertrand Knebelmann, Paris |
Project Period: |
07/2020 - 05/2021 |
Sponsors: |
Industry |
ClinicalTrials.gov: |
NCT04340362 |
EudraCT Nr.: |
2020-000185-42 |
« Back to research page